McConaghy boats has acquired the brand and intellectual property of Cure Marine, Australian builder of high-performance sailing catamarans.
The acquisition signals a new chapter for the Cure Marine series, with a potential production partnership evolving into a full integration of the brand into the McConaghy portfolio.
Under the new structure, McConaghy will take over the manufacturing of the Cure range, transitioning production to McConaghy’s facilities to leverage its existing composite engineering and autoclave technologies.
Cure Marine has now concluded operations, with production of the Cure range transitioning to McConaghy.
We saw a unique opportunity to bring a successful Australian design into the McConaghy fold.
Mark Evans
As part of the transition, McConaghy has appointed Ed Penn as sales manager for the Cure series.
Ed, who was involved in Cure’s initial success, joins the McConaghy team to lead the brand’s global commercial efforts.
“We saw a unique opportunity to bring a successful Australian design into the McConaghy fold,” explained Mark Evans, McConaghy group managing director.
“By combining Cure’s performance-driven IP with McConaghy’s global production scale and technical expertise, we are ensuring a bright and sustainable future for these exceptional catamarans.”
He added: “We are also delighted to welcome Ed Penn to the McConaghy team as sales manager for the Cure series, bringing over 30 years of industry experience and ensuring continuity and expertise for our clients.”
New iterations
McConaghy is already undertaking a design evolution of the Cure 55GT and Cure 48GT models, with further details on the new iterations expected to be unveiled later in April.
McConaghy has stated it will continue to collaborate with the original design team.
McConaghy has been developing and building high-performance boats for more than 50 years using advanced composite construction techniques and the latest marine technology.
The company has facilities in both China, Hong Kong and Sydney.
Cure Marine was founded in 2005 and has built some of Australia’s most acclaimed performance multihulls, with models including the Cure 48, Cure 55 and Cure 68.
